Source: BioPortfolio

KHB: Shanghai Kehua Bioengineering Co Ltd 002022 Financial and Strategic SWOT Analysis Review Report Updated 16082018 Prices from USD $125

Shanghai Kehua Bioengineering Co Ltd 002022 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an...

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
CEO Avatar

General Manager

Xiaodong Jin

CEO Approval Rating

64/100

Read more